MDL | MFCD00953146 |
---|---|
Molecular Weight | 360.45 |
Molecular Formula | C20H28N2O4 |
SMILES | O=C(OCCCC1=CC=CN=C1)[C@H]2N(C(C(C(C)(C)CC)=O)=O)CCC2 |
GPI-1046 is a immunophilin ligand without antibiotic action and attenuates ethanol intake in part through the upregulation of glutamate transporter 1 (GLT1) in PFC and NAc-core. GPI-1046 is an analog of FK506, which is an immunophilin ligand that has been shown neuroprotective effects in neurodegenerative disease models [1] . GPI-1046 readily crosses the blood-brain barrier and promotes the regeneration of dopamine (DA) cells in the CNS in association with functional recovery in rodent models [2] . GPI-1046 improves HIV -associated injury of peripheral nerves [3] .
GLT1 |
Liquid
Room temperature in continental US; may vary elsewhere.
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
DMSO : ≥ 100 mg/mL ( 277.43 mM )
* "≥" means soluble, but saturation unknown.
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.7743 mL | 13.8715 mL | 27.7431 mL |
5 mM | 0.5549 mL | 2.7743 mL | 5.5486 mL |
10 mM | 0.2774 mL | 1.3872 mL | 2.7743 mL |